ISSCR News
Fish-like Genetic Program Used to Turn Human Retinal Cells Into Neurons
New research by Thomas Reh, Juliette Wohlschlegel, and colleagues at the University of Washington, USA, published in the journal Stem Cell Reports, shows that human Muller glia can be coaxed into changing identity in the laboratory, which could serve as a potential source of new neurons to treat vision loss.
Camouflaging Stem Cell-Derived Transplants Avoids Immune Rejection
To overcome both the risks of immune rejection and of potential tumor formation during cell and organ transplantation, researchers Baoyang Hu and colleagues from the Chinese Academy of Sciences, Beijing, have genetically engineered stem cells so that liver cells obtained from them would be invisible to the immune system.
ISSCR and Cell Press Renew Publishing Agreement for Stem Cell Reports
The International Society for Stem Cell Research (ISSCR) and publisher Cell Press are extending their partnership to publish the ISSCR’s open access, peer-reviewed journal, Stem Cell Reports. For more than a decade, Stem Cell Reports has served as an important point of convergence for the stem cell research and regenerative medicine field.
The ISSCR Opens Registration and Abstract Submission for 2024 Annual Meeting in Hamburg, Germany
ISSCR 2024 is the most clinically focused annual meeting in the society’s 20+ years. Fueled by basic research and unparalleled development of new technologies, the field is seeing more stem cell-based clinical trials than at any time in history. The meeting serves as an incubator, a catalyst for new advances at each point in the research continuum.
ISSCR Launches Website to Inform Patients and the Public About Stem Cells
“The ISSCR has a long history of sharing scientifically validated information about the potential of stem cell research and clinical advances with the public,” said Amander T. Clark, ISSCR President. “Our reimagined website, AboutStemCells.org, gives us an important avenue to educate the public about the importance of our work, combat misinformation, and raise awareness for the dangers of using unproven and unapproved stem cell-based treatments.”
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .